Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Clinical trials show it could help people lose weight and improve their health
Nausea most common, affects ~30-40% of patients during titration
When used as monotherapy, tirzepatide has a very low risk of causing clinically significant hypoglycemia (less than 0.6% incidence), similar to placebo, due to its glucose-dependent mechanism of action that limits insulin secretion when blood sugar approaches normal levels
N Engl J Med (2017) 377:64457
Dng mi ngy vo bui sng
US$ 29.47
US$ 26.55
US$ 29.09
US$ 28.84
US$ 25.79
US$ 28.60
US$ 20.72
